Filing Details
- Accession Number:
- 0001491519-20-000002
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2020-01-08 12:38:10
- Reporting Period:
- 2019-12-31
- Accepted Time:
- 2020-01-08 12:38:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896747 | American Bio Medica Corp | ABMC | Pharmaceutical Preparations (2834) | 141702188 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1491519 | Chaim Davis | C/O Abmc 122 Smith Road Kinderhook NY 12106 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2018-06-21 | 33,784 | $0.10 | 58,507 | No | 5 | A | Direct | |
| Common Shares | Acquisiton | 2018-10-15 | 35,036 | $0.09 | 93,543 | No | 5 | A | Direct | |
| Common Shares | Acquisiton | 2019-01-23 | 38,993 | $0.08 | 132,536 | No | 5 | A | Direct | |
| Common Shares | Acquisiton | 2019-06-20 | 27,415 | $0.07 | 159,951 | No | 5 | A | Direct | |
| Common Shares | Acquisiton | 2019-10-10 | 37,398 | $0.09 | 197,349 | No | 5 | A | Direct | |
| Common Shares | Acquisiton | 2019-01-23 | 500,000 | $0.10 | 2,449,915 | No | 5 | P | Indirect | By Revach Fund, LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 5 | A | Direct | |
| No | 5 | A | Direct | |
| No | 5 | A | Direct | |
| No | 5 | A | Direct | |
| No | 5 | P | Indirect | By Revach Fund, LP |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Non-Statutory Stock Option | Acquisiton | 2013-04-26 | 50,000 | $0.18 | 50,000 | $0.18 |
| Common Shares | Non-Statutory Stock Option | Acquisiton | 2018-06-21 | 20,000 | $0.10 | 20,000 | $0.10 |
| Common Shares | Non-Statutory Stock Option | Acquisiton | 2019-06-20 | 20,000 | $0.07 | 20,000 | $0.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,000 | 2014-04-26 | 2023-04-26 | No | 5 | J | Direct |
| 20,000 | 2019-06-21 | 2028-06-21 | No | 5 | J | Direct |
| 20,000 | 2020-06-20 | 2029-06-20 | No | 5 | J | Direct |
Footnotes
- Previously reported on Form 4.
- The common shares are in the name of Revach Fund, LP. The reporting person (Davis) is a managing member of Revach Group, LLC which operates as the general partner for the Revach Fund, LP.
Billionaire Hedge Funds
